E-LIB Suche - Ergebnisse für: Shumel, B.

1

Efficacy and safety of dupilumab treatment with concomitant..:

Paller, A.S. ; Pinter, A. ; Lee, L. Wine...
Revue Française d'Allergologie. 63 (2023) 3 - p. 103411 , 2023

Link: https://doi.org/10.1016/..

2

POSA13 Dupilumab Treatment Reduces Hospitalizations in Adul..:

Silverberg, J ; Rubini, N ; Pires, MC...
Value in Health. 25 (2022) 1 - p. S20 , 2022

Link: https://doi.org/10.1016/..

3

IGAxBSA composite for assessing disease severity and respon..:

Paller, A.S. ; Tan, J.K.L. ; Bagel, J....
British Journal of Dermatology. 186 (2022) 3 - p. 496-507 , 2022

Link: https://doi.org/10.1111/..

4

Dupilumab safety and efficacy up to 52 weeks in adult and a..:

Dellon, E.S. ; Rothenberg, M.E. ; Collins, M.H....
Revue Française d'Allergologie. 62 (2022) 3 - p. 372 , 2022

Link: https://doi.org/10.1016/..

5

Laboratory safety of dupilumab in moderate-to-severe atopic..:

Wollenberg, A. ; Beck, L.A. ; Blauvelt, A....
British Journal of Dermatology. 182 (2020) 5 - p. 1120-1135 , 2020

Link: https://doi.org/10.1111/..

6

Assessing the need for routine safety testing for patients ..:

Wollenberg, A ; Beck, L.A. ; Blauvelt, A....
British Journal of Dermatology. 182 (2020) 6 - p. , 2020

Link: https://doi.org/10.1111/..

7

Dupilumab provides rapid and sustained improvement in SCORA..:

Barbarot, S. ; Wollenberg, A. ; Silverberg, J. I....
Journal of Dermatological Treatment. 33 (2020) 1 - p. 266-277 , 2020

Link: https://doi.org/10.1080/..

8

Response to R. Waldmanet al.: 'Does IL‐4 inhibition play a ..:

Ardeleanu, M. ; Shumel, B. ; Rossi, A.B..
British Journal of Dermatology. 182 (2020) 5 - p. 1310-1312 , 2020

Link: https://doi.org/10.1111/..

9

Un traitement par le dupilumab d'une durée allant jusqu'à 3..:

Blauvelt, A. ; Hussain, I. ; Beazley, B...
Annales de Dermatologie et de Vénéréologie. 147 (2020) 12 - p. A361-A362 , 2020

Link: https://doi.org/10.1016/..

10

评估接受 Dupilumab 治疗的中度至重度特应性皮炎患者进行常规安全性检测的必要性:

Wollenberg, A. ; Beck, L.A. ; Blauvelt, A....
British Journal of Dermatology. 182 (2020) 6 - p. , 2020

Link: https://doi.org/10.1111/..

11

Conjunctivitis in dupilumab clinical trials:

Akinlade, B. ; Guttman‐Yassky, E. ; Bruin‐Weller, M....
British Journal of Dermatology. 181 (2019) 3 - p. 459-473 , 2019

Link: https://doi.org/10.1111/..

12

Efficacy and safety of dupilumab in Japanese adults with mo..:

Katoh, N. ; Kataoka, Y. ; Saeki, H....
British Journal of Dermatology. 183 (2019) 1 - p. 39-51 , 2019

Link: https://doi.org/10.1111/..

13

Effets à long terme du dupilumab sur les valeurs du SCORAD ..:

Herranz Pinto, P. ; de Bruin-Weller, M. ; Shumel, B....
Annales de Dermatologie et de Vénéréologie. 146 (2019) 12 - p. A211 , 2019

Link: https://doi.org/10.1016/..

14

Dupilumab 临床试验中的结膜炎:

Akinlade, B. ; Guttman‐Yassky, E. ; Bruin‐Weller, M....
British Journal of Dermatology. 181 (2019) 3 - p. , 2019

Link: https://doi.org/10.1111/..

15

Conjunctivitis in dupilumab clinical trials:

Akinlade, B. ; Guttman‐Yassky, E. ; Bruin‐Weller, M....
British Journal of Dermatology. 181 (2019) 3 - p. , 2019

Link: https://doi.org/10.1111/..